相似文献
1
How deep is our anxiety during treatment of thyroid cancer?
Arch Endocrinol Metab. 2018 Jun;62(3):273-274. doi: 10.20945/2359-3997000000051.
2
What is the role of radionuclide sentinel lymph node biopsy and dissection in papillary thyroid cancer?
Nucl Med Commun. 2015 Oct;36(10):969-70. doi: 10.1097/MNM.0000000000000327.
3
Can lymphoscintigraphy and gamma probe method in sentinel node biopsy for differentiated thyroid carcinoma obviate the disadvantages of the blue-dye method?
Eur J Surg Oncol. 2007 Aug;33(6):815-6. doi: 10.1016/j.ejso.2006.12.008. Epub 2007 Jan 10.
4
SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement.
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1645-55. doi: 10.1007/s00259-013-2476-x. Epub 2013 Aug 2.
5
Sentinel lymph node biopsy in differentiated thyroid cancer: standard of care or experimental tool?
Nucl Med Commun. 2006 Nov;27(11):833-5. doi: 10.1097/MNM.0b013e328011022c.
6
[Identification of sentinel lymph nodes in thyroid carcinoma].
Acta Chir Iugosl. 2003;50(3):103-6. doi: 10.2298/aci0303103d.
7
Sentinel lymph node dissection for thyroid malignancy.
Recent Results Cancer Res. 2000;157:201-5. doi: 10.1007/978-3-642-57151-0_17.
8
Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial.
Eur Arch Otorhinolaryngol. 2015 Apr;272(4):971-979. doi: 10.1007/s00405-014-3018-2. Epub 2014 Apr 3.
9
Sentinel node biopsy in papillary thyroid cancer--what is the potential?
Langenbecks Arch Surg. 2014 Feb;399(2):245-51. doi: 10.1007/s00423-014-1168-8. Epub 2014 Jan 21.
10
The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.
JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):834-41. doi: 10.1001/jamaoto.2016.1227.
本文引用的文献
1
Accuracy of sentinel lymph node mapping in detecting occult neck metastasis in papillary thyroid carcinoma.
Arch Endocrinol Metab. 2018 Jun;62(3):296-302. doi: 10.20945/2359-3997000000038. Epub 2018 May 17.
2
Predictive factors of outcome in poorly differentiated thyroid carcinomas.
Eur J Cancer. 2018 Mar;92:40-47. doi: 10.1016/j.ejca.2017.12.027. Epub 2018 Feb 3.
3
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020. doi: 10.1001/jamaoto.2017.1442.
4
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.
Endocr Rev. 2017 Aug 1;38(4):351-378. doi: 10.1210/er.2017-00067.
5
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16.
6
7
The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
Surgery. 2008 Dec;144(6):1070-7; discussion 1077-8. doi: 10.1016/j.surg.2008.08.034.
8
Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis.
Head Neck. 2005 Sep;27(9):739-47. doi: 10.1002/hed.20228.
9
Technical details of intraoperative lymphatic mapping for early stage melanoma.
Arch Surg. 1992 Apr;127(4):392-9. doi: 10.1001/archsurg.1992.01420040034005.
Zotero 插件